Mixed Phenotype Acute Leukemia, B/Myeloid (Bilineal and Biphenotypic), With t(2;22)(q35;q12);EWSR1-FEV

J Pediatr Hematol Oncol. 2021 Apr 1;43(3):e388-e394. doi: 10.1097/MPH.0000000000001934.

Abstract

Background: Ewing sarcoma breakpoint region 1 gene (EWSR1) rearrangements are largely associated with the Ewing sarcoma family of tumors.

Observations: We report the first case of infantile, mixed phenotype acute leukemia, B/myeloid (bilineal and biphenotypic [B-lymphoid and B-lymphoid/myeloid]), with a t(2;22)(q35;q12). The EWSR1-fifth Ewing variant gene fusion and nonsense mutation in STAG2 were detected by next-generation sequencing and markedly high expression of fifth Ewing sarcoma variant mRNA detected by quantitative reverse transcription polymerase chain reaction. The patient was treated with a combined myeloid/lymphoid leukemia regimen followed by allogeneic stem cell transplant and was in complete remission at 3.8-year follow-up.

Conclusions: Our case study underscores the importance of a comprehensive evaluation of acute leukemia and provides insights into the phenotype of EWSR1 rearranged neoplasms in the context of partner genes and cell type.

Publication types

  • Case Reports

MeSH terms

  • Cell Cycle Proteins / genetics
  • Codon, Nonsense
  • DNA-Binding Proteins / genetics*
  • Female
  • Humans
  • Infant
  • Leukemia, Biphenotypic, Acute / genetics*
  • Leukemia, Myeloid, Acute / genetics*
  • Oncogene Proteins, Fusion / genetics*
  • RNA-Binding Protein EWS / genetics*
  • Transcription Factors / genetics*
  • Translocation, Genetic

Substances

  • Cell Cycle Proteins
  • Codon, Nonsense
  • DNA-Binding Proteins
  • EWSR1 protein, human
  • FEV protein, human
  • Oncogene Proteins, Fusion
  • RNA-Binding Protein EWS
  • STAG2 protein, human
  • Transcription Factors